Phase 2SuspendedGeroscience intervention

Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease

Frailty, Inflammation, and Stem Cell Functionality in Chronic Kidney Disease

Sponsor
Mayo Clinic (Academic or other)
Enrollment
30 planned
Conditions
Chronic Kidney Diseases; Diabetes Mellitus; Diabetic Nephropathies
Interventions
Fisetin; Placebo oral capsule
Ages
adults, older adults
Registry
NCT03325322

Full record on ClinicalTrials.gov

From the registry

The proposed studies will examine the effect of fisetin on adipose tissue-derived mesenchymal stem/stromal cell function, kidney function, markers of inflammation, and physical function in individuals with advanced chronic kidney disease.

Primary outcomes

  • Change in inflammatory markers including C-reactive protein
  • Effect on Mesenchymal stem cell function including cell migration

History

  1. Primary completion expected

  2. Last registry update

  3. Started

  4. Registered

Papers citing this trial